If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Emea Regulatory News (JEMA)

Share Price Information for Jpmorgan Emea (JEMA)

Share Price is delayed by 15 minutes
Get Live Data
242.00    5.00 (2.11%)
Bid:
235.00
Ask:
248.00
Spread: 13.00 (5.532%)
Market Cap: £97.86m
JEMA Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Emea Share Chart

Russian Court Cases - Update

8 Jun 2026 17:04

RNS Number : 4623H
JPMorgan Emerging EMEA Securities
08 June 2026
Β 

Β 

LONDON STOCK EXCHANGE ANNOUNCEMENT

Β 

Β 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC

(the 'Company' or 'JEMA')

Β 

Legal Entity Identifier: 549300II3MHI98ZLVH37

Β 

Russian Court Cases - Update

Β 

Further to the Board's previous RNS announcements regarding the lawsuits filed by VTB Bank in Russia claiming $439.5m, $81.3 million, $74.5 million and €108 million and the lawsuit filed by Sberbank in Russia claiming $830,183 against eight J.P. Morgan legal entities and the Company,Β the Board announces the following updates from JPMorgan Funds Limited (the Company's Manager) (in italics):

Β 

VTB Bank claims ($81.3 million, $74.5 million and €108 million):

Claims withdrawn.

Β 

Further to the announcement on 16th February 2026, on 3rd June 2026 and 8th June 2026 respectively, the Russian Court accepted VTB Bank's motion to withdraw the claims in response to the Anti-Suit Injunction granted in the English Court and cancelled the associated freezing orders over JPM's assets.

Β 

VTB Bank claim ($439.5 million):

Appeal filed to a higher court, the Court of Cassation in Russia, is currently suspended.

Β 

The Court of Cassation has indicated that it does not intend to schedule a further hearing until the appeals filed by the relevant J.P. Morgan legal entities to the Supreme Court in a separate claim unrelated to the Company have been considered.

Β 

Sberbank claim ($830,183):

Hearing date now 13th July 2026.

Β 

Β 

The Board will provide further updates as the cases progress.

Β 

8th June 2026

Β 

For further information:

Β 

Joel Clopon, Neil Martin, JPMorgan Funds Limited 0800 20 40 20

Hugh Jonathan, Deutsche Numis 020 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FURUPUGUQUPQGQR
Date   Source Headline
26th Feb 202610:38 amRNSNet Asset Value(s)
25th Feb 202610:21 amRNSNet Asset Value(s)
24th Feb 202610:43 amRNSNet Asset Value(s)
23rd Feb 202611:24 amRNSNet Asset Value(s)
20th Feb 202611:06 amRNSNet Asset Value(s)
19th Feb 202610:42 amRNSNet Asset Value(s)
18th Feb 202610:26 amRNSNet Asset Value(s)
17th Feb 202610:52 amRNSNet Asset Value(s)
16th Feb 20265:47 pmRNSRussian Court Cases - Update
16th Feb 202611:24 amRNSNet Asset Value(s)
13th Feb 202611:21 amRNSNet Asset Value(s)
13th Feb 202610:31 amRNSTen Largest Investments
12th Feb 202611:10 amRNSNet Asset Value(s)
11th Feb 202610:42 amRNSNet Asset Value(s)
10th Feb 202610:46 amRNSNet Asset Value(s)
9th Feb 202611:00 amRNSNet Asset Value(s)
6th Feb 202610:49 amRNSNet Asset Value(s)
5th Feb 202611:49 amRNSNet Asset Value(s)
4th Feb 202611:41 amRNSNet Asset Value(s)
3rd Feb 202611:07 amRNSNet Asset Value(s)
2nd Feb 202611:37 amRNSNet Asset Value(s)
30th Jan 202611:20 amRNSNet Asset Value(s)
30th Jan 20267:02 amRNSDividend Declaration
30th Jan 20267:00 amRNSFinal Results
29th Jan 202611:01 amRNSNet Asset Value(s)
28th Jan 202611:42 amRNSNet Asset Value(s)
28th Jan 20269:57 amRNSHolding(s) in Company
27th Jan 202610:36 amRNSNet Asset Value(s)
26th Jan 202610:52 amRNSNet Asset Value(s)
23rd Jan 202610:36 amRNSNet Asset Value(s)
22nd Jan 202611:11 amRNSNet Asset Value(s)
21st Jan 202610:42 amRNSNet Asset Value(s)
20th Jan 20262:08 pmRNSRussian Court Cases Update
20th Jan 202610:59 amRNSNet Asset Value(s)
19th Jan 202610:55 amRNSNet Asset Value(s)
16th Jan 202611:04 amRNSNet Asset Value(s)
15th Jan 202610:54 amRNSNet Asset Value(s)
14th Jan 202611:15 amRNSNet Asset Value(s)
13th Jan 20263:56 pmRNSTen Largest Investments
13th Jan 202610:45 amRNSNet Asset Value(s)
12th Jan 202610:47 amRNSNet Asset Value(s)
9th Jan 202611:08 amRNSNet Asset Value(s)
8th Jan 202611:03 amRNSNet Asset Value(s)
7th Jan 202611:26 amRNSNet Asset Value(s)
6th Jan 202610:37 amRNSNet Asset Value(s)
5th Jan 202610:49 amRNSNet Asset Value(s)
2nd Jan 202611:36 amRNSNet Asset Value(s)
31st Dec 202510:56 amRNSNet Asset Value(s)
30th Dec 202511:05 amRNSNet Asset Value(s)
29th Dec 202512:03 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.